in recent research a new series of specific drugs , one of which is guanabenz ( gbz , 2,6 ( dichlorobenzyliden ) -aminoguanidine ) has been introduced into the clinical treatment of centrally mediated hypertension .
C0018312
gbz
C0020538
hypertension